Kings College Hospital
London, England SE5 9RS
1 studies enrolling now · 17 studies all time
What they study most
AML, Acute Alcoholic Hepatitis, Acute Kidney Injury, Community-acquired Pneumonia, Influenza, COVID-19, Crigler-Najjar Syndrome, Crohn's Disease, Diabetic Macular Edema, Heart Failure, Hepatitis C Virus Infection, Hepatitis C, Chronic, Infection, Leukemia
Studies at this site
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
- Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial — Running, not enrolling
- SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction — Completed
- A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection — Stopped early
- Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough — Completed
- A Study of CK-1827452 Infusion in Stable Heart Failure — Completed
- (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive — Completed
- Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) — Completed
- A Study of Fibrocaps™ in Surgical Bleeding — Completed
- Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure — Completed
- Clinical Assessment Study in Crigler-Najjar Syndrome — Completed
- Gilead Sustained Virologic Response (SVR) Registry — Completed
- A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response — Completed
- Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia — Completed
- VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia — Completed
- Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury — Completed
- Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis — Completed